Main > ONCOLOGY (**) > MyeloFibrosis *** > Treatment > USA. I. Ruxolitinib Tab

---

USA. I. Ruxolitinib Tab's subsections
(*) USA Approval Date: 2011. 11.16
Company
JAK 1/2 Inhibitor.
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 8
Patent>UpDate: 2018. 11.20.
TradeMark
TradeMark Web-Site

USA. I. Ruxolitinib Tab's products
This section has no products